This can only mean further delays. The trial endpoints will no longer be guaranteed by the FDA. Maybe the success of Nexavar is putting pressure on them to give priority review to Bayer.
This can only mean further delays. The trial endpoints will no...
Add to My Watchlist
What is My Watchlist?